Custom service

Custom Antibody Fragmentation

Fab, F(ab')2, Fc and half-antibody, cut where you need the cut.

Formats: Fab / F(ab')2 / Fc — plus half-IgG and scFvTimeline: 2–3 weeks — from antibody to QC'd fragmentPurity: >95% — by SEC-HPLC

Not every assay can accommodate a 150 kDa molecule. A sandwich ELISA suffers when the Fc region binds protein A in the sample or when rheumatoid factor bridges capture and detection antibodies; immunohistochemistry on tissue with endogenous Fc receptors produces background that no blocking step fully removes; and in vivo work changes entirely when the effector function is deleted. Fragmentation solves these problems without redesigning the antibody.

Papain digests below the hinge and releases two Fab fragments, each a single antigen-binding arm. Pepsin digests above the hinge and leaves F(ab')2, a bivalent fragment with the hinge disulfides intact and the Fc removed. For mouse IgG1 — which resists pepsin — a pre-treatment with pepsin at low pH or a switch to ficin is used. Fc fragments are recovered from papain digests by protein A capture of the intact Fc, followed by SEC.

The chemistry is old, but the QC is what separates a usable fragment from a mixture. Every preparation is checked by SDS-PAGE under reducing and non-reducing conditions, by SEC-HPLC for aggregation and residual intact IgG, and by binding ELISA to confirm that the paratope survived the digest. A Fab that no longer binds is not a Fab, it is a protein mixture.

Service Highlights

Where it fits

Fab and F(ab')2 are standard in tissue staining, in sandwich assays where Fc interactions interfere, and in crystallography where the smaller fragment yields better crystals. Fc fragments are used as blocking reagents and as controls for effector-function studies.

Fragmentation is not always possible. Some IgGs resist digestion at every condition tried, and some fragments lose affinity once the bivalent avidity contribution is removed — a low-affinity antibody that works as an IgG may fail as a Fab. In both cases recombinant expression of the fragment is the fallback.

Documentation and QC

Each preparation is released with a reducing and non-reducing SDS-PAGE, an SEC-HPLC chromatogram reporting monomer, aggregate and residual intact IgG, and a binding ELISA compared with the parent IgG. Fragment identity is confirmed by molecular weight under reducing conditions.

Frequently asked questions

Will the Fab have the same affinity as the IgG?

The intrinsic affinity of each arm is unchanged, but the observed avidity drops because bivalent binding is lost. For antibodies with KD below 10 nM this is rarely noticeable in an ELISA; for weaker binders the signal can fall substantially.

Can you fragment a mouse IgG1 with pepsin?

Mouse IgG1 is a poor pepsin substrate. We either use ficin or papain, or digest at low pH with a longer incubation, and the choice is made in the trial digestion rather than assumed.

Can the fragment be conjugated?

Yes. F(ab')2 retains hinge thiols after mild reduction, which allows site-directed maleimide conjugation away from the paratope.

Tell us the format and the application. If the parent antibody is a weak binder, we will flag the avidity loss before digesting, because a Fab is not always the answer.

Service Highlights

  • Papain, pepsin and ficin. Enzyme and condition selected per isotype, since mouse IgG1, IgG2a and human IgG1 behave differently at the same pH.
  • Hinge-aware digestion. Time and enzyme-to-substrate ratio titrated to maximise the desired fragment while limiting over-digestion to small peptides.
  • Separation by affinity and size. Protein A removes Fc and intact IgG, followed by SEC to resolve F(ab')2 dimer from Fab monomer.
  • Binding verified after digestion. ELISA against the original antigen confirms that the paratope is intact, which is the only meaningful release criterion.
  • Conjugation-ready. Free thiols generated at the hinge are available for site-directed labelling without touching the CDRs.
  • Recombinant alternative. Where digestion fails, the fragment is expressed recombinantly from the parent sequence.

How the work runs

  1. Isotype and buffer review

    Isotype determines the enzyme: pepsin for human IgG1 and mouse IgG2a, papain for mouse IgG1, ficin as a general fallback. Buffer pH and EDTA are set accordingly.

  2. Small-scale digestion trial

    Immobilised or in-solution digestion at several enzyme-to-substrate ratios, analysed by SDS-PAGE to select the condition that gives the cleanest fragment.

  3. Preparative digestion

    Scale-up under the selected condition, stopped with iodoacetamide or by pH adjustment, and dialysed into the purification buffer.

  4. Purification

    Protein A or protein G capture to remove Fc and intact IgG; SEC to separate F(ab')2 from Fab and from aggregates.

  5. QC

    SDS-PAGE reducing and non-reducing, SEC-HPLC, A280 concentration, and binding ELISA against the original antigen.

  6. Formatting

    Buffer exchange into PBS or the assay buffer, optional conjugation, and 0.22 µm filtration for sterile supply.

Specifications & timeline

Formats
Fab / F(ab')2 / Fc — plus half-IgG and scFv
Timeline
2–3 weeks — from antibody to QC'd fragment
Purity
>95% — by SEC-HPLC
Formats
Fab, F(ab')2, Fc, half-IgG, scFv (recombinant)
Starting material
1–50 mg purified IgG, or a hybridoma supernatant we purify first
Enzymes
Papain, pepsin, ficin, IdeS for half-antibody generation
Purity
>95% by SEC-HPLC; residual intact IgG below 2%
Timeline
2–3 weeks including trial digestion and QC
Deliverables
0.5–20 mg fragment, SDS-PAGE, SEC chromatogram, binding ELISA

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.